BW Communities

Articles for Healthcare

St. Jude Medical To Launch HeartMate 3 Left Ventricular Assist System In India

The HeartMate 3 System offers physicians in India the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure

Read More
Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

The company's shares rose as much as 4 per cent to Rs 786.80 in early trade on Tuesday, while the broader market was down 0.15 per cent

Read More
India Approves First Stem Cell-based Drug For Buerger's Disease

The drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease

Read More
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors

Read More
How Not To Burn Yourself

Don’t eat roadside foods. Unless you trust the source, avoid fresh juices, junk foods like paani puri, cut fruits or salads outside

Read More
Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More
Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More
Ajanta Pharma Gets USFDA Approval Of Zolmitriptan Tablets

USFDA has granted Ajanta Pharma 9 ANDA final approvals and two tentative approvals. Additional 15 ANDAs are under review with the American regulator

Read More

Subscribe to our newsletter to get updates on our latest news